We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.
- Authors
Iwasawa, Taiji; Zhang, Pu; Ohkawa, Yuki; Momota, Hiroyuki; Wakabayashi, Toshihiko; Ohmi, Yuhsuke; Bhuiyan, Robiul H.; Furukawa, Keiko; Furukawa, Koichi
- Abstract
Sialic acid-containing glycosphingolipids, gangliosides, are considered as cancer associated antigens in neuro-ectoderm-derived tumors such as melanomas and neuroblastomas. In particular, gangliosides GD3 and GD2 are expressed in human gliomas. It has been reported that their expression levels increase along with increased malignant properties. However, the implication of GD3/GD2 in human glioma cells has never been clarified, at least to the best of our knowledge. In this study, we introduced the cDNA of GD3 synthase (GD3S)(ST8SIA1) into a glioma cell line, U-251MG, that expresses neither GD3 nor GD2, thereby establishing transfectant cells U-251MG-GD3S(+) expressing high levels of GD3 and GD2 on the cell surface. In these U-251MG-GD3S(+) cell lines, signaling molecules such as Erk1/2, Akt, p130Cas, paxillin and focal adhesion kinase were activated, leading to the enhancement of invasion activity and motility. It was then demonstrated that the U-251MG-GD3S(+) cells could proliferate under culture conditions with low or no serum concentrations without undergoing cell cycle arrest by escaping the accumulation of p16 and p21. All these results suggested that GD3 and GD2 highly expressed in gliomas confer increased invasion and mobility, cell growth abilities under low serum conditions, and increased ratios of the S-G2/M phase in the cell cycle.
- Publication
International Journal of Oncology, 2018, Vol 52, Issue 4, p1255
- ISSN
1019-6439
- Publication type
Article
- DOI
10.3892/ijo.2018.4266